Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Associations between candidate genes with schizophrenia susceptibility and the treatment efficiency].

Psychiatria polska - 1 Jan 2000

Tybura Piotr, Grzywacz Anna, Samochowiec Agnieszka, Samochowiec Jerzy

Abstract excerpt

AIM: The aim of the study was to find genetic markers which can have influence on susceptibility of paranoid schizophrenia and the treatment efficiency measured by the PANSS (Positive and Negative Syndrome Scale). We analysed the gene polymorphisms: dopamine receptor--DRD2 (Taq 1A, in egzon 8,- 141 C ins/del), dopamine transporter--DAT, kainate receptor--GRIK3, serotonine transporter--SERT, serotonine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Analysis of Variance
Share to Antipsychotic Agents
Share to Chi-Square Distribution

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Membrane Glycoproteins

Share to Poland

Share to Quality of Life

Share to Schizophrenia, Paranoid

Share to Schizophrenic Psychology

Source

Identifiers

PMID: 22335125

Genes

COMT
DRD2
GRIK3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Associations between candidate genes with schizophrenia susceptibility and the treatment efficiency].PMID 22335125Read ↗

Risk Genes in Schizophrenia and Their Importance in Choosing the Appropriate Antipsychotic Treatment.Semantic proximity Read ↗

[Polymorphism of RGS2 gene: genetic markers of risk for schizophrenia and pharmacogenetic markers of typical neuroleptics efficiency].Semantic proximity Read ↗

Some dopaminergic genes polymorphisms are not associated with response to antipsychotic drugs in schizophrenic patients.Semantic proximity Read ↗

[Glutamate receptors genes polymorphism and the risk of paranoid schizophrenia in Russians and tatars from the Republic of Bashkortostan].Semantic proximity Read ↗

Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features.Semantic proximity Read ↗

[The study of candidates' genes in psychiatric diseases. I. Schizophrenia].Semantic proximity Read ↗

Indicated association between polygenic risk score and treatment-resistance in a naturalistic sample of patients with schizophrenia spectrum disordersSemantic proximity Read ↗

[Functional polymorphism of genes inactivating catecholamines and emotional deficits in paranoid schizophrenia].Semantic proximity Read ↗

[Genetics of schizophrenia: advances in the study of candidate genes].Semantic proximity Read ↗

[Relationship between genetic polymorphisms of 3 SNP loci in 5-HTT gene and paranoid schizophrenia].Semantic proximity Read ↗

[The Role of Neurotrophins and Neurexins Genes in the Risk of Paranoid Schizophrenia in Russians and Tatars].Semantic proximity Read ↗

Genetic polymorphisms in dopaminergic system and treatment-resistant schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.